The latest survey from Wolters Kluwer sheds light on the pressing issue of drug diversion in healthcare settings. With a staggering 81% of healthcare leaders admitting that drug diversion is still happening, the findings underscore the urgent need for advanced technology and collaboration across departments to tackle this silent threat effectively.
Key Points
- Only one-third of healthcare leaders feel “very confident” in their drug diversion prevention programs.
- A significant 81% of surveyed leaders believe drug diversion incidents remain largely unreported.
- Despite investments, gaps in enforcement and shifts in departmental involvement hinder progress.
- Less than half of respondents currently utilise AI tools, yet a majority express interest in implementing advanced analytics.
- Collaboration across various departments, including anesthesiology and HR, is critical but often lacking.
Why should I read this?
If you’re in healthcare or just interested in how tech can help tackle drug misuse, this article is a must-read. It highlights the real challenges and solutions, revealing a vital conversation about drug diversion that everyone in the industry needs to be part of. Don’t miss out on insights that could help shape safer, more efficient healthcare practices!
